Notify me when Cystic Fibrosis Foundation files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PHGE | BiomX Inc. | Common Stock, $0.0001 par value per share | 10% | $349,175 | -$887,608 | 2,494,110 | -39% | Cystic Fibrosis Foundation | 27 Feb 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|